Molecular Engineering Strategies Tailoring the Apoptotic Response to a MET Therapeutic Antibody

Cancers - Switzerland
doi 10.3390/cancers12030741
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Tailoring the Immune Response to Nutrients' Availability

FEBS Journal
BiochemistryCell BiologyMolecular Biology
2020English

Antibody Drug Conjugates: Future Directions in Clinical and Translational Strategies to Improve the Therapeutic Index

Clinical Cancer Research
Cancer ResearchOncology
2019English

Dysregulation of Apoptotic Signaling in Cancer: Molecular Mechanisms and Therapeutic Opportunities

Journal of Cellular Biochemistry
BiochemistryCell BiologyMolecular Biology
2008English

Thyroid Cancer: Molecular Aspects and New Therapeutic Strategies

Journal of Thyroid Research
EndocrinologyMetabolismDiabetes
2012English

A Genomics Approach to Therapeutic Antibody Target Discovery

Nature Genetics
Genetics
2001English

Improved Effector Functions of a Therapeutic Monoclonal Lewis Y-Specific Antibody by Glycoform Engineering

Cancer Research
Cancer ResearchOncology
2005English

Monovalent Antibody Design and Mechanism of Action of Onartuzumab, a MET Antagonist With Anti-Tumor Activity as a Therapeutic Agent

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2013English

Anti-Met VHH Pool Overcomes MET-targeted Cancer Therapeutic Resistance

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Engineering Strategies to Recapitulate the Tumor Microenvironment

2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy